Skip to content
healthcare.dev

Deflazacort Oral Suspension

NDC 27808-249, Deflazacort Oral, suspension, from Cranbury Pharmaceuticals, LLC.

Product NDC
27808-249
Status
Listed
Labeler
Cranbury Pharmaceuticals, LLC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217813
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/27808-249 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFLAZACORT22.75 mg/mL

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

Package NDCNDC-11Package
27808-249-012780802490113 mL in 1 BOTTLE (27808-249-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/881785a5-41b4-4679-a29b-5d77ca51ca60

Use it

Look up 27808-249 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/27808-249 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 27808-249. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.